269 related articles for article (PubMed ID: 11356895)
21. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
22. Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats.
Okano K; Kuraishi Y; Satoh M
Jpn J Pharmacol; 1998 Jan; 76(1):15-22. PubMed ID: 9517400
[TBL] [Abstract][Full Text] [Related]
23. Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats.
Hama A; Woon Lee J; Sagen J
Eur J Pharmacol; 2003 Jan; 459(1):49-58. PubMed ID: 12505533
[TBL] [Abstract][Full Text] [Related]
24. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
Célèrier E; Laulin J; Larcher A; Le Moal M; Simonnet G
Brain Res; 1999 Nov; 847(1):18-25. PubMed ID: 10564731
[TBL] [Abstract][Full Text] [Related]
25. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery.
Gardell LR; King T; Ossipov MH; Rice KC; Lai J; Vanderah TW; Porreca F
Neurosci Lett; 2006 Mar; 396(1):44-9. PubMed ID: 16343768
[TBL] [Abstract][Full Text] [Related]
26. Role of mu-opioid and NMDA receptors in the development and maintenance of repeated swim stress-induced thermal hyperalgesia.
Suarez-Roca H; Silva JA; Arcaya JL; Quintero L; Maixner W; Pinerua-Shuhaibar L
Behav Brain Res; 2006 Feb; 167(2):205-11. PubMed ID: 16214233
[TBL] [Abstract][Full Text] [Related]
27. Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: behavioral and neurochemical aspects.
Scheggi S; Mangiavacchi S; Masi F; Gambarana C; Tagliamonte A; De Montis MG
Neuroscience; 2002; 109(2):267-74. PubMed ID: 11801363
[TBL] [Abstract][Full Text] [Related]
28. Blockade of NMDA receptors prevents analgesic tolerance to repeated transcutaneous electrical nerve stimulation (TENS) in rats.
Hingne PM; Sluka KA
J Pain; 2008 Mar; 9(3):217-25. PubMed ID: 18061543
[TBL] [Abstract][Full Text] [Related]
29. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
30. Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats.
Begon S; Pickering G; Eschalier A; Mazur A; Rayssiguier Y; Dubray C
Br J Pharmacol; 2001 Nov; 134(6):1227-36. PubMed ID: 11704642
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
[TBL] [Abstract][Full Text] [Related]
32. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
McNally GP; Westbrook RF
Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
[TBL] [Abstract][Full Text] [Related]
33. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
[TBL] [Abstract][Full Text] [Related]
34. Buprenorphine-induced hyperalgesia in the rat.
Wala EP; Holtman JR
Eur J Pharmacol; 2011 Jan; 651(1-3):89-95. PubMed ID: 21114985
[TBL] [Abstract][Full Text] [Related]
35. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
36. Endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization Via a NMDA-dependent process.
Le Roy C; Laboureyras E; Gavello-Baudy S; Chateauraynaud J; Laulin JP; Simonnet G
J Pain; 2011 Oct; 12(10):1069-79. PubMed ID: 21723199
[TBL] [Abstract][Full Text] [Related]
37. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
[TBL] [Abstract][Full Text] [Related]
38. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist.
Davis AM; Inturrisi CE
Brain Res; 2001 Mar; 894(1):150-3. PubMed ID: 11245826
[TBL] [Abstract][Full Text] [Related]
40. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
